share_log

Chromocell Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Motif Pharmaceuticals Ltd.(8.4%)

Chromocell Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Motif Pharmaceuticals Ltd.(8.4%)

Chromocell Therapeutics | SC 13G:超過5%持股股東披露文件-Motif Pharmaceuticals Ltd.(8.4%)
美股SEC公告 ·  03/01 17:16
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息